MarketCap
Facebook
X
Telegram
ThermoGenesis Holdings Financial Ratios 2023-2009 | THMO
Brief overview of ThermoGenesis Holdings's valuation multiples
Ratios are assessed across five available annual reports in the 2018–2022 interval.
Market valuation is represented by P/S 0.2x (median 0.7x), P/B 0.63x (median 1.01x). Multiples are on average 54.7% below their own medians. Shares look cheaper than their recent historical valuation.
Returns on assets and capital are represented by ROE 11.3%, ROA -168.4%, ROCE 5.2%. Current return ratios are negative, materially weakening the fundamental profile.
The cash conversion cycle decreased 14.4 days to 126.6 days, supporting working-capital efficiency.
What the ratios show
ThermoGenesis Holdings's discount may reflect genuine profitability issues rather than market inefficiency alone.
Annual Financial Ratios ThermoGenesis Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | -0.2 | -0.0 | -1.1 | -1.1 | -0.2 | -125.7 | -9.2 | -6.0 | -511.0 | -2377.8 | -611.4 | -1165.9 | - | - |
P/S |
- | 0.2 | 0.0 | 1.8 | 0.9 | 0.7 | 47.7 | 19.9 | 5.5 | 275.9 | 408.5 | 160.2 | 127.9 | - | - |
EPS |
-7.6 | -20.4 | -43.4 | -2.6 | -3.4 | -21.6 | -0.2 | -3.3 | -7.4 | -0.4 | -0.2 | -0.3 | -0.2 | -0.0 | - |
EV (Enterprise Value) |
12.8 M | 14 M | 10.1 M | 25.7 M | 22.4 M | 12.3 M | 301 M | 249 M | 101 M | 4.41 B | 7.34 B | 3.05 B | 2.98 B | -10.7 M | -6.66 M |
EBITDA per Share |
-3.15 | -9.56 | -25.2 | -1.3 | -1.39 | -23.3 | -0.42 | -0.55 | -6.7 | -0.33 | -0.15 | -0.29 | -0.16 | 0.41 | - |
EV/EBITDA |
-1.7 | -2.7 | -1.5 | -3.2 | -5.7 | -0.3 | -70.5 | -57.2 | -7.5 | -548.0 | -2903.1 | -637.8 | -1260.0 | -1.9 | - |
PEG |
- | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.33 | -0.02 | -0.02 | 0.04 | -0.17 | 0.04 | -0.13 | - | - |
P/B |
- | 0.6 | 0.0 | 3.0 | 12.3 | 1.0 | 8.6 | 7.3 | 2.5 | 90.6 | 551.0 | 191.7 | 149.0 | - | - |
P/CF |
- | -0.3 | -0.0 | -1.2 | -3.5 | -1.0 | -86.5 | -24.6 | -8.3 | -562.9 | -2380.9 | -784.6 | -1430.6 | - | - |
ROE % |
1134.91 | -274.95 | -310.34 | -289.84 | -2616.32 | -484.96 | -6.77 | -80.08 | -42.55 | -17.72 | -23.17 | -31.36 | -12.78 | -2.73 | - |
ROA % |
-168.44 | -60.93 | -57.52 | -80.59 | -66.38 | -280.20 | -4.47 | -51.79 | -29.26 | -13.72 | -16.65 | -23.65 | -10.52 | - | - |
ROCE % |
516.50 | -144.16 | -188.90 | -60.73 | -59.17 | -437.33 | -10.16 | -12.45 | -34.71 | -16.00 | -22.91 | -33.52 | -13.94 | 29.55 | - |
Current Ratio |
0.8 | 1.2 | 1.2 | 1.4 | 1.1 | 1.9 | 2.9 | 2.8 | 3.2 | 4.4 | 3.6 | 4.1 | 5.7 | - | - |
DSO |
54.4 | 45.2 | 41.5 | 49.8 | 39.0 | 60.3 | 147.4 | 127.0 | 111.8 | 109.5 | 96.1 | 81.7 | 30.9 | - | - |
DIO |
115.1 | 204.4 | 353.9 | 201.3 | 198.0 | 226.7 | 396.9 | 309.0 | 164.9 | 178.2 | 166.0 | 181.8 | 79.6 | - | - |
DPO |
42.9 | 49.3 | 83.2 | 60.5 | 96.1 | 109.9 | 223.6 | 291.5 | 140.1 | 121.0 | 92.5 | 65.6 | 22.4 | - | - |
Operating Cycle |
169.5 | 249.7 | 395.5 | 251.2 | 237.0 | 287.0 | 544.3 | 436.0 | 276.7 | 287.7 | 262.1 | 263.5 | 110.5 | - | - |
Cash Conversion Cycle |
126.6 | 200.3 | 312.2 | 190.7 | 140.9 | 177.2 | 320.7 | 144.5 | 136.6 | 166.7 | 169.6 | 197.9 | 88.0 | - | - |
All numbers in USD currency
Quarterly Financial Ratios ThermoGenesis Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.46 | - | -1.44 | -0.91 | -4.07 | - | -0.1 | -0.2 | -0.16 | - | -0.15 | -0.38 | -0.21 | - | -0.37 | -1.02 | -1.11 | - | -0.78 | -0.47 | -0.08 | - | -0.12 | -1.73 | -0.27 | - | -0.21 | -0.35 | -0.24 | -0.35 | -4 | -0.02 | -0.08 | -0.3 | -0.12 | -0.11 | -0.08 | -0.11 | -0.07 | -0.1 | -0.14 | -0.1 | -0.07 | -0.03 | 0.06 | -0.03 | -0.11 | -0.08 | -0.07 | -0.08 | -0.07 | -0.08 | -0.07 |
EBITDA per Share |
-0.06 | - | -0.3 | -0.48 | -0.62 | - | -0.04 | -0.08 | -0.09 | - | -0.05 | -0.24 | -0.13 | - | -0.08 | -0.76 | -0.24 | - | -0.04 | -0.03 | -0.03 | - | -0.08 | -1.96 | -0.28 | - | -0.15 | -0.31 | -0.22 | -0.36 | -0.69 | -0.03 | -0.09 | -0.95 | -0.09 | -0.09 | -0.07 | -0.11 | -0.04 | -0.08 | -0.13 | -0.1 | -0.11 | -0.08 | -0.13 | -0.03 | 0.08 | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 |
ROE % |
-434.39 | -229.15 | -295.89 | -259.83 | -308.00 | -222.78 | -250.93 | -242.23 | -221.05 | -110.34 | -193.64 | -295.33 | -349.79 | -325.64 | -385.81 | -328.28 | -236.90 | -124.40 | -142.30 | -344.23 | -328.97 | -290.52 | -297.11 | -289.31 | -35.54 | -25.02 | -35.11 | -58.91 | -50.75 | -52.95 | -44.79 | -27.40 | -35.98 | -32.67 | -41.25 | -32.77 | -38.90 | -52.34 | -58.47 | -61.16 | -47.92 | -21.39 | -8.15 | -11.63 | -15.24 | -27.37 | -30.98 | -26.57 | -25.92 | -25.66 | -6.27 | -6.36 | -6.01 |
ROA % |
-83.18 | -63.35 | -80.28 | -69.93 | -67.44 | -41.21 | -49.08 | -53.00 | -50.59 | -39.45 | -54.54 | -80.31 | -85.23 | -74.50 | -87.99 | -81.82 | -61.28 | -35.51 | -48.31 | -151.67 | -149.47 | -136.37 | -140.85 | -135.16 | -23.58 | -16.87 | -23.97 | -40.24 | -34.44 | -35.69 | -29.89 | -18.15 | -24.65 | -23.68 | -30.18 | -25.11 | -28.49 | -36.87 | -40.25 | -42.09 | -33.64 | -14.91 | -6.45 | -8.69 | -11.69 | -21.64 | -24.65 | -21.80 | -21.31 | -21.09 | -5.17 | -5.24 | -4.95 |
ROCE % |
-153.32 | -96.19 | -135.71 | -125.16 | -145.78 | -128.60 | -145.95 | -145.42 | -137.95 | -72.21 | -106.79 | -192.90 | -182.60 | -166.73 | -175.09 | -145.09 | -58.64 | -29.97 | -42.49 | -328.49 | -334.08 | -317.06 | -323.71 | -321.80 | -35.00 | -24.83 | -35.44 | -36.45 | -31.95 | -36.52 | -32.02 | -37.42 | -41.78 | -36.85 | -41.21 | -32.67 | -38.83 | -52.30 | -58.47 | -68.73 | -61.77 | -54.64 | -41.37 | -20.58 | -13.54 | -3.37 | 6.01 | - | - | - | - | - | - |
Current Ratio |
0.9 | 0.8 | 1.3 | 1.2 | 1.3 | 1.2 | 1.3 | 1.4 | 1.1 | 1.2 | 1.4 | 1.5 | 1.8 | 1.4 | 1.2 | 1.4 | 1.3 | 1.1 | 1.4 | 1.6 | 1.7 | 1.9 | 2.8 | 1.6 | 2.6 | 2.9 | 3.1 | 3.4 | 2.7 | 3.4 | 3.2 | 3.0 | 2.6 | 3.0 | 3.3 | 3.5 | 3.7 | - | 3.3 | 1.0 | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
35.0 | - | 23.8 | 34.7 | 50.0 | - | 94.2 | 67.5 | 49.8 | - | 55.1 | 42.9 | 66.4 | - | 64.9 | 75.0 | 47.1 | - | 85.0 | 53.9 | 54.0 | - | 57.2 | 76.6 | 79.1 | - | 88.8 | 83.7 | 90.1 | 80.4 | 90.9 | 41.8 | 86.2 | 127.2 | 166.3 | 123.8 | 144.5 | 99.5 | 138.5 | 95.8 | 121.7 | 107.0 | 128.9 | 90.6 | 111.1 | 96.2 | 108.0 | 89.2 | 104.0 | 89.7 | 78.6 | 75.7 | - |
DIO |
78.8 | - | 113.5 | 153.8 | 210.2 | - | 282.9 | 248.6 | 298.3 | - | 253.5 | 418.6 | 632.3 | - | 598.1 | 88.1 | 205.7 | - | 155.2 | 160.1 | 235.7 | - | 176.1 | 288.5 | 301.7 | - | 153.4 | 128.7 | 147.7 | 116.9 | 141.3 | 160.2 | 147.8 | 181.1 | 160.6 | 163.0 | 204.8 | 147.0 | 163.8 | 146.3 | 174.0 | 145.1 | 137.4 | 186.7 | 211.3 | 189.7 | 161.4 | 198.6 | 213.3 | 198.6 | 206.2 | 188.6 | - |
DPO |
57.5 | - | 27.9 | 36.5 | 54.5 | - | 61.1 | 67.8 | 83.3 | - | 58.6 | 91.9 | 151.9 | - | 264.7 | 53.3 | 104.3 | - | 107.0 | 109.7 | 130.8 | - | 71.1 | 124.1 | 135.3 | - | 97.0 | 76.2 | 87.4 | 100.4 | 146.2 | 202.8 | 187.1 | 183.4 | 123.6 | 90.9 | 114.2 | 91.3 | 105.3 | 101.4 | 120.6 | 70.7 | 39.9 | 46.9 | 53.1 | 57.6 | 46.7 | 51.5 | 55.3 | 51.5 | 57.6 | 53.2 | - |
Operating Cycle |
113.8 | - | 137.3 | 188.5 | 260.3 | - | 377.1 | 316.1 | 348.1 | - | 308.6 | 461.5 | 698.7 | - | 689.0 | 166.3 | 288.0 | - | 190.1 | 175.3 | 265.6 | - | 211.0 | 318.6 | 357.9 | - | 254.9 | 265.9 | 250.0 | 182.5 | 207.8 | 105.0 | 225.4 | 258.8 | 301.1 | 327.4 | 338.7 | 250.9 | 325.5 | 257.1 | 308.6 | 245.9 | 289.6 | 245.1 | 323.0 | 270.9 | 317.8 | 289.7 | 344.7 | 288.3 | 284.8 | 264.4 | - |
Cash Conversion Cycle |
56.3 | - | 109.4 | 152.1 | 205.7 | - | 316.0 | 248.3 | 264.8 | - | 250.0 | 369.5 | 546.7 | - | 541.3 | 140.7 | 212.8 | - | 129.0 | 119.2 | 162.0 | - | 121.1 | 183.8 | 222.3 | - | 166.2 | 169.7 | 149.3 | 110.3 | 122.3 | 55.0 | 90.1 | 55.9 | 101.8 | 122.8 | 185.5 | 160.0 | 203.6 | 151.5 | 191.6 | 144.4 | 161.6 | 139.3 | 231.8 | 224.0 | 239.7 | 200.2 | 263.9 | 236.8 | 227.2 | 211.1 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company ThermoGenesis Holdings, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
France
China
Israel
Britain
Canada
